Wolverine Trading’s Enzo Biochem, Inc. ENZ Stock Holding History

Wolverine Trading’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-12,600	Closed	-$30K	–	5109
2023 Q1	$30K	Buy	+12,600	New	+$18.7K	﹤0.01%	3947
2021 Q4	–	Sell	-14,500	Closed	-$51K	–	7052
2021 Q3	$51K	Buy	+14,500	New	+$48.4K	﹤0.01%	6014
2021 Q2	–	Sell	-11,700	Closed	-$38K	–	6878
2021 Q1	$38K	Buy	+11,700	New	+$36.4K	﹤0.01%	5704
2020 Q4	–	Sell	-10,000	Closed	-$21K	–	5614
2020 Q3	$21K	Buy	+10,000	New	+$23.8K	﹤0.01%	4384
2020 Q2	–	Sell	-16,200	Closed	-$41K	–	5375
2020 Q1	$41K	Buy	+16,200	New	+$39.8K	﹤0.01%	4319
2019 Q4	–	Sell	-10,100	Closed	-$37K	–	5337
2019 Q3	$37K	Buy	+10,100	New	+$35.7K	﹤0.01%	4100
2017 Q4	–	Sell	-23,800	Closed	-$249K	–	5618
2017 Q3	$249K	Buy	+23,800	New	+$264K	﹤0.01%	3533
2016 Q4	–	Sell	-20,400	Closed	-$100K	–	5305
2016 Q3	$100K	Sell	20,400 -7,300	-26%	-$43.6K	﹤0.01%	4193
2016 Q2	$161K	Buy	+27,700	New	+$154K	﹤0.01%	3420

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PCM

Potomac Capital Management New York $115M AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's ENZ Position: Q1 2023 in Review

Wolverine Trading sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 21,266 shares — an estimated $31.6K sold.

Wolverine Trading first reported a position in ENZ in Q3 2017 and held it in 9 quarters. The position peaked at $173K in Q1 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

Wolverine Trading reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
Wolverine Trading sold 21,266 Enzo Biochem, Inc. shares in Q1 2023, an estimated $31.6K.
Wolverine Trading first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 9 quarters.
Wolverine Trading's Enzo Biochem, Inc. position peaked at $173K in Q1 2021.
52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Wolverine Trading's 13F filing for Q1 2023, filed 15 May 2023.